Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Exagen Inc. (XGN)

10.84   -0.18 (-1.63%) 09-30 18:08
Open: 11.525 Pre. Close: 11.02
High: 11.525 Low: 10.31
Volume: 8,634 Market Cap: 137M
Exagen, Inc. is a commercial-stage diagnostics company. The company is headquartered in Vista, California and currently employs 82 full-time employees. The firm offers physicians testing for patients and healthcare providers in diagnosis, prognosis and monitoring of autoimmune conditions. Its diagnostic tests include AVISE connective tissue disease (CTD), AVISE Lupus and AVISE antiphospholipid syndrome (APS). Its prognostic tests include AVISE systemic lupus erythematosus (SLE) Prognostic, AVISE Platelet-bound C4d (PC4d) and AVISE Anti- carbamylated proteins (CarP). Its monitoring tests include AVISE SLE Monitor, AVISE methotrexate (MTX) and AVISE hydroxychloroquine (HCQ).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.959 - 11.011 11.011 - 11.058
Low: 10.807 - 10.87 10.87 - 10.927
Close: 10.838 - 10.94 10.94 - 11.032

Technical analysis

as of: 2020-09-30 4:48:09 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 17.06     One year: 20.03
Support: Support1: 10.48    Support2: 8.72
Resistance: Resistance1: 14.60    Resistance2: 17.15
Pivot: 11.92
Moving Average: MA(5): 10.82     MA(20): 12.14
MA(100): 12.85     MA(250): 16.02
MACD: MACD(12,26): -0.81     Signal(9): -0.64
Stochastic oscillator: %K(14,3): 10.57     %D(3): 8.41
RSI: RSI(14): 35.95
52-week: High: 29.86  Low: 10.29  Change(%): -26.1
Average Vol(K): 3-Month: 3208  10-Days: 922

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
XGN has closed above bottom band by 25.0%. Bollinger Bands are 5.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 29 Sep 2020
Exagen Inc. Announces Agreement with Provider Network of America Expanding Access for AVISE® Tests to 8 Million Members - GlobeNewswire

Wed, 23 Sep 2020
Exagen Appoints Wendy Johnson to Board of Directors - GlobeNewswire

Tue, 22 Sep 2020
Is Exagen (NASDAQ:XGN) Using Too Much Debt? - Yahoo Finance

Mon, 21 Sep 2020
Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV) - GlobeNewswire

Tue, 28 Jul 2020
Exagen Inc. (XGN) Q2 2020 Earnings Call Transcript - The Motley Fool

Mon, 27 Jul 2020
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East - GlobeNewswire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 13
Shares Float (M) 3
% Held by Insiders 34.02
% Held by Institutions 57.80
Shares Short (K) 220
Shares Short P. Month (K) 214

Stock Financials

EPS -72.270
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.670
Profit Margin -39.49
Operating Margin -34.33
Return on Assets (ttm) -14.8
Return on Equity (ttm) -64.3
Qtrly Rev. Growth -14.6
Gross Profit (p.s.) 1.707
Sales Per Share 3.100
EBITDA (p.s.) -1.026
Qtrly Earnings Growth
Operating Cash Flow (M) -14
Levered Free Cash Flow (M) -10

Stock Valuations

PE Ratio -0.15
PEG Ratio
Price to Book value 2.34
Price to Sales 3.53
Price to Cash Flow -10.13

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.